Schroder Investment Management Group Bio Techne Corp Transaction History

Schroder Investment Management Group

$101 Billion
Q4 2024

A detailed history of Schroder Investment Management Group transactions in Bio Techne Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 4,465 shares of TECH stock, worth $219,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,465

Previous 7,699 42.01%

Holding current value

$219,142

Previous $615,000 47.8%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$66.37 - $78.17 $214,640 - $252,801	-3,234 Reduced 42.01%	4,465 $321,000
Q2 2024 Aug 12, 2024	SELL	$62.12 - $84.15 $1.47 Million - $2 Million	-23,716 Reduced 75.49%	7,699 $551,000
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $1.58 Million - $1.84 Million	23,883 Added 317.09%	31,415 $2.21 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $69,850 - $81,423	-947 Reduced 11.17%	7,532 $614,000
Q1 2023 May 11, 2023	SELL	$71.62 - $86.62 $4.84 Million - $5.86 Million	-67,621 Reduced 88.86%	8,479 $629,000
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $4.6 Million - $20.1 Million	57,075 Added 300.0%	76,100 $6.31 Million
Q3 2022 Nov 10, 2022	BUY	$282.54 - $391.85 $27,123 - $37,617	96 Added 0.51%	19,025 $5.4 Million
Q2 2022 Aug 11, 2022	SELL	$322.67 - $449.65 $262,330 - $365,565	-813 Reduced 4.12%	18,929 $6.6 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $3.11 Million - $4.29 Million	8,801 Added 80.44%	19,742 $8.73 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $4.79 Million - $5.51 Million	-10,493 Reduced 48.95%	10,941 $5.66 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $10.2 Million - $12.4 Million	-23,031 Reduced 51.8%	21,434 $10.4 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $3.89 Million - $4.53 Million	10,052 Added 29.21%	44,465 $20 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $13.2 Million - $17.2 Million	-41,964 Reduced 54.94%	34,413 $13.1 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $6.24 Million - $8.14 Million	-25,280 Reduced 24.87%	76,377 $24.3 Million
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $1.29 Million - $1.58 Million	-5,575 Reduced 5.2%	101,657 $25.1 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $711,309 - $1.07 Million	-3,836 Reduced 3.45%	107,232 $28.3 Million
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $5.93 Million - $8.15 Million	-36,802 Reduced 24.89%	111,068 $21.6 Million
Q4 2019 Feb 11, 2020	SELL	$189.68 - $222.09 $10.2 Million - $12 Million	-53,915 Reduced 26.72%	147,870 $32.5 Million
Q3 2019 Nov 12, 2019	BUY	$183.56 - $216.72 $8.34 Million - $9.84 Million	45,412 Added 29.04%	201,785 $39.8 Million
Q2 2019 Aug 08, 2019	SELL	$188.72 - $215.43 $9.48 Million - $10.8 Million	-50,252 Reduced 24.32%	156,373 $32.6 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $1.82 Million - $2.68 Million	13,356 Added 6.91%	206,625 $41 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $6.59 Million - $10.1 Million	49,637 Added 34.56%	193,269 $28 Million
Q3 2018 Nov 13, 2018	SELL	$147.44 - $204.11 $8.41 Million - $11.6 Million	-57,032 Reduced 28.42%	143,632 $29.3 Million
Q2 2018 Aug 24, 2018	SELL	$144.9 - $165.58 $291 Million - $333 Million	-2,010,838 Reduced 90.93%	200,664 $29.5 Million
Q2 2018 Aug 13, 2018	BUY	$144.9 - $165.58 $291 Million - $332 Million	2,005,804 Added 975.12%	2,211,502 $85.5 Million
Q1 2018 May 11, 2018	SELL	$131.46 - $151.04 $8.68 Million - $9.97 Million	-66,042 Reduced 24.3%	205,698 $31.1 Million
Q4 2017 Feb 09, 2018	SELL	$121.17 - $134.75 $7.88 Million - $8.77 Million	-65,071 Reduced 19.32%	271,740 $35.2 Million
Q3 2017 Nov 09, 2017	BUY	$113.59 - $123.78 $38.3 Million - $41.7 Million	336,811	336,811 $40.6 Million

Others Institutions Holding TECH

# of Institutions

616

Shares Held

154M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $1.93B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Bio Techne Corp Transaction History